David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PINC
1701
DELISTED
Premier
PINC
| $3.35M | 0.01% |
102,536
-94,600
| -48% | -$3.09M |
|
|
NVMI
1702
Nova
NVMI
$11.7B
| $3.34M | 0.01% |
102,433
-34,652
| -25% | -$1.26M |
|
|
IVC
1703
DELISTED
Invacare Corporation
IVC
| $3.34M | 0.01% |
449,925
-388,893
| -46% | -$3.01M |
|
|
ROIC
1704
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $3.34M | 0.01% |
402,991
+351,016
| +675% | +$5.22M |
|
1705
CALL
Stryker
SYK
$127B
| $3.33M | 0.01% |
20,000
-4,100
| -17% | -$801K |
|
1706
CALL
T. Rowe Price
TROW
$24.1B
| $3.32M | 0.01% |
34,000
-2,300
| -6% | -$282K |
|
1707
Huntington Ingalls Industries
HII
$11.5B
| $3.31M | 0.01% |
18,186
-9,664
| -35% | -$2.25M |
|
1708
Colliers International
CIGI
$5.39B
| $3.31M | 0.01% |
69,200
-35,600
| -34% | -$2.67M |
|
1709
PUT
Lumen
LUMN
$6.08B
| $3.31M | 0.01% |
350,000
-20,100
| -5% | -$251K |
|
1710
CALL
C.H. Robinson
CHRW
$16.8B
| $3.31M | 0.01% |
50,000
+40,000
| +400% | +$2.87M |
|
1711
Bio-Rad Laboratories Class A
BIO
$10.4B
| $3.31M | 0.01% |
9,428
-3,146
| -25% | -$1.16M |
|
1712
PUT
HP
HPQ
$27B
| $3.3M | 0.01% |
190,000
-20,800
| -10% | -$421K |
|
1713
PUT
Novartis
NVS
$304B
| $3.3M | 0.01% |
40,000
-1,100
| -3% | -$98.1K |
|
1714
NovoCure
NVCR
$2.05B
| $3.29M | 0.01% |
48,921
-57,392
| -54% | -$4.54M |
|
1715
PUT
Southwest Airlines
LUV
$20B
| $3.27M | 0.01% |
91,900
-63,900
| -41% | -$3.17M |
|
1716
PUT
Everest Group
EG
$14.4B
| $3.27M | 0.01% |
17,000
+12,700
| +295% | +$3.24M |
|
1717
Digital Realty Trust
DLR
$71.2B
| $3.27M | 0.01% |
23,515
+10,081
| +75% | +$1.28M |
|
1718
BridgeBio Pharma
BBIO
$15.7B
| $3.27M | 0.01% |
+112,589
| New | +$3.49M |
|
1719
The Bancorp
TBBK
$2.73B
| $3.26M | 0.01% |
536,973
-172,231
| -24% | -$1.84M |
|
|
NUVA
1720
DELISTED
NuVasive, Inc.
NUVA
| $3.26M | 0.01% |
64,269
-17,719
| -22% | -$1.19M |
|
1721
Alexandria Real Estate Equities
ARE
$9.1B
| $3.25M | 0.01% |
+23,748
| New | +$3.72M |
|
|
FBC
1722
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $3.25M | 0.01% |
164,023
+9,043
| +6% | +$293K |
|
|
THCAU
1723
DELISTED
Tuscan Holdings Corp. II Unit
THCAU
| $3.25M | 0.01% |
325,000
| – | – |
|
1724
PUT
BorgWarner
BWA
$13.3B
| $3.25M | 0.01% |
151,429
+86,450
| +133% | +$2.5M |
|
1725
CALL
Franco-Nevada
FNV
$52.4B
| $3.24M | 0.01% |
32,600
| – | – |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.